logo
Share SHARE
FONT-SIZE Plus   Neg

Agios Pharmaceuticals Files For IPO Of Up To $86 Mln

Biopharmaceutical company Agios Pharmaceuticals Inc has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission to raise up to $86 million in an initial public offering of common stock. The company did not specify the number of shares to be sold and the price range for the proposed offering.

The Cambridge, Massachusetts-based company said in a preliminary prospectus that it intends to list its common stock on the Nasdaq under the symbol "AGIO".

The company, which was founded in 2007, specified that JP Morgan and Goldman Sachs & Co are lead underwriters in the IPO.

In April 2010, Agios entered into a collaboration agreement with Celgene corp (CELG.O) on a program focused on cancer metabolism.

Agios reported a net loss of $7.2 million on revenue of $6.3 million for the quarter ended March 31, according to the filing.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
10 Worst Places To Raise A Family Whether you are a young couple building a nest or seasoned parents looking for a change of scenery, there are number of places around the country that should be avoided, according to personal finance website WalletHub. They looked at mainly five categories for... A passenger has filed a lawsuit against Canadian budget airline Sunwing Airlines for serving him cheap sparkling wine instead of champagne on board a flight, according to media reports. The Canadian passenger, Daniel MacDuff, reportedly boarded his Sunwing flight to Cuba in February, on a flight package that advertised a complimentary on-board champagne toast. Senate Health Committee Chairman Lamar Alexander, R-Tenn., and ranking member Patty Murray, D-Wash., announced Thursday that twenty-two other Senators are cosponsoring their bipartisan plan to provide short-term stability to Obamacare. The bipartisan bill includes a two-year extension of the cost-sharing...
comments powered by Disqus
Follow RTT